Position in DYN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$47,911,300
+$16,671,208 QoQ
Shares Held
2,157,195
+25.2% QoQ
Ownership
1.16%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#23
of 245 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. DYN ranks #66 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in DYN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $47,911,300 | 2,157,195 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $31,240,092 | 1,723,116 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $44,659,215 | 2,283,191 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $24,037,719 | 1,900,215 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $12,761,016 | 1,340,443 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $10,406,506 | 994,886 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $14,812,241 | 628,703 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $24,083,784 | 670,484 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $73,958,981 | 2,095,749 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $47,158,288 | 1,661,088 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $15,438,267 | 1,160,772 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $13,512,952 | 1,508,142 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $22,607,200 | 2,009,529 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $17,216,063 | 1,494,450 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $9,689,436 | 836,017 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $5,049,138 | 397,570 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $453,715 | 66,043 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $757,288 | 78,557 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,006,106 | 84,618 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $637,728 | 39,269 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $3,832,351 | 182,146 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,592,026 | 102,513 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $939,099 | 44,719 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,593,557 | 177,987 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||